SE9802793D0 - New compounds - Google Patents

New compounds

Info

Publication number
SE9802793D0
SE9802793D0 SE9802793A SE9802793A SE9802793D0 SE 9802793 D0 SE9802793 D0 SE 9802793D0 SE 9802793 A SE9802793 A SE 9802793A SE 9802793 A SE9802793 A SE 9802793A SE 9802793 D0 SE9802793 D0 SE 9802793D0
Authority
SE
Sweden
Prior art keywords
new compounds
prevention
formula
treatment
acceptable salts
Prior art date
Application number
SE9802793A
Other languages
English (en)
Swedish (sv)
Inventor
Kosrat Amin
Mikael Dahlstroem
Peter Nordberg
Ingemar Starke
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9802793A priority Critical patent/SE9802793D0/xx
Publication of SE9802793D0 publication Critical patent/SE9802793D0/xx
Priority to JP2000566272A priority patent/JP2002523414A/ja
Priority to KR1020017002151A priority patent/KR20010072797A/ko
Priority to AU57678/99A priority patent/AU770511B2/en
Priority to PT99944965T priority patent/PT1105390E/pt
Priority to ES99944965T priority patent/ES2201769T3/es
Priority to DK99944965T priority patent/DK1105390T3/da
Priority to CA002339372A priority patent/CA2339372A1/fr
Priority to PCT/SE1999/001401 priority patent/WO2000010999A2/fr
Priority to IL14116599A priority patent/IL141165A0/xx
Priority to US09/403,510 priority patent/US6613775B1/en
Priority to BR9913102-1A priority patent/BR9913102A/pt
Priority to AT99944965T priority patent/ATE242242T1/de
Priority to CNB998121770A priority patent/CN1161355C/zh
Priority to SI9930370T priority patent/SI1105390T1/xx
Priority to NZ509744A priority patent/NZ509744A/en
Priority to EP99944965A priority patent/EP1105390B1/fr
Priority to DE69908608T priority patent/DE69908608T2/de
Priority to MYPI99003559A priority patent/MY121387A/en
Priority to ARP990104162A priority patent/AR020225A1/es
Priority to ZA200100911A priority patent/ZA200100911B/en
Priority to NO20010861A priority patent/NO20010861L/no
Priority to HK01106665A priority patent/HK1036274A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE9802793A 1998-08-21 1998-08-21 New compounds SE9802793D0 (sv)

Priority Applications (23)

Application Number Priority Date Filing Date Title
SE9802793A SE9802793D0 (sv) 1998-08-21 1998-08-21 New compounds
DE69908608T DE69908608T2 (de) 1998-08-21 1999-08-18 Derivate von Imidazo[1,2-a]pyridin zur Behandlung von gastrointestinalen Krankheiten
US09/403,510 US6613775B1 (en) 1998-08-21 1999-08-18 Imidazo[1,2-a]pyridine compounds
AT99944965T ATE242242T1 (de) 1998-08-21 1999-08-18 Derivate von imidazo(1,2-a)pyridin zur behandlung von gastrointestinalen krankheiten
AU57678/99A AU770511B2 (en) 1998-08-21 1999-08-18 New compounds
PT99944965T PT1105390E (pt) 1998-08-21 1999-08-18 Derivados de imidazo¬1,2-a|piridina para o tratamento de doencas gastrointestinais
ES99944965T ES2201769T3 (es) 1998-08-21 1999-08-18 Derivados de imizado (1,2-a)piridina para el tratamiento de enfermedades gasttrointestinales.
DK99944965T DK1105390T3 (da) 1998-08-21 1999-08-18 Imidazo(1,2a)pyridinderivater til behandling af gastrointestinale sygdomme
CA002339372A CA2339372A1 (fr) 1998-08-21 1999-08-18 Nouveaux composes
PCT/SE1999/001401 WO2000010999A2 (fr) 1998-08-21 1999-08-18 Nouveaux composes
IL14116599A IL141165A0 (en) 1998-08-21 1999-08-18 New imidazopyridine compounds for the inhibition of acid secretion, pharmaceutical compositions thereof and process for preparing the same
JP2000566272A JP2002523414A (ja) 1998-08-21 1999-08-18 新規な化合物
BR9913102-1A BR9913102A (pt) 1998-08-21 1999-08-18 Composto, produtos contento um composto, processo para preparação de um composto, formulação farmacêutica contento um composto, uso de um composto, processos para inibir a secreção de ácido gástrico, para o tratamento de doenças inflamatórias gastrintestinais e, para o tratamento ou profilaxia de condições que envolvam a infecção por helicobacter pylori da mucosa gástrica humana, e, formulação farmacêutica
KR1020017002151A KR20010072797A (ko) 1998-08-21 1999-08-18 신규 화합물
CNB998121770A CN1161355C (zh) 1998-08-21 1999-08-18 新的化合物
SI9930370T SI1105390T1 (en) 1998-08-21 1999-08-18 Imidazo(1,2-a)pyridine derivatives for the treatment of gastrointestinal diseases
NZ509744A NZ509744A (en) 1998-08-21 1999-08-18 8-benzylaminopyridines for inhibiting gastric acid secretion
EP99944965A EP1105390B1 (fr) 1998-08-21 1999-08-18 Dérivés de imidazo[1,2-a]pyridine pour le traitement de maladies gastrointestinales
ARP990104162A AR020225A1 (es) 1998-08-21 1999-08-19 Compuestos, productos que los contienen, procesos para su preparacion, formulaciones farmaceuticas, y usos de dichos compuestos
MYPI99003559A MY121387A (en) 1998-08-21 1999-08-19 Imidazo[1,2-a]pyridine derivatives for the treatment of gastrointestinal diseases
ZA200100911A ZA200100911B (en) 1998-08-21 2001-02-01 New compounds.
NO20010861A NO20010861L (no) 1998-08-21 2001-02-20 Nye forbindelser
HK01106665A HK1036274A1 (en) 1998-08-21 2001-09-20 Imidazo (1,2-a) pyridine derivatives for the treatment of gastrointestinal diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9802793A SE9802793D0 (sv) 1998-08-21 1998-08-21 New compounds

Publications (1)

Publication Number Publication Date
SE9802793D0 true SE9802793D0 (sv) 1998-08-21

Family

ID=20412306

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9802793A SE9802793D0 (sv) 1998-08-21 1998-08-21 New compounds

Country Status (22)

Country Link
US (1) US6613775B1 (fr)
EP (1) EP1105390B1 (fr)
JP (1) JP2002523414A (fr)
KR (1) KR20010072797A (fr)
CN (1) CN1161355C (fr)
AR (1) AR020225A1 (fr)
AT (1) ATE242242T1 (fr)
AU (1) AU770511B2 (fr)
BR (1) BR9913102A (fr)
CA (1) CA2339372A1 (fr)
DE (1) DE69908608T2 (fr)
DK (1) DK1105390T3 (fr)
ES (1) ES2201769T3 (fr)
HK (1) HK1036274A1 (fr)
IL (1) IL141165A0 (fr)
MY (1) MY121387A (fr)
NO (1) NO20010861L (fr)
NZ (1) NZ509744A (fr)
PT (1) PT1105390E (fr)
SE (1) SE9802793D0 (fr)
WO (1) WO2000010999A2 (fr)
ZA (1) ZA200100911B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
SE9802794D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
CA2503290C (fr) 2003-03-10 2012-12-04 Altana Pharma Ag Nouveau procede de preparation de roflumilast
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
EP1670795A1 (fr) * 2003-09-18 2006-06-21 ALTANA Pharma AG Imidazo¬4,5-c|pyridines substituees au position 6
CN1874772A (zh) 2003-11-03 2006-12-06 阿斯利康(瑞典)有限公司 治疗隐匿性胃食管反流的咪唑并[1,2－a]吡啶衍生物
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
CA2575345A1 (fr) * 2004-08-02 2006-02-09 Altana Pharma Ag 1h-pyrrolo[3,2-b]pyridines 5-substituees
KR101068355B1 (ko) * 2005-03-09 2011-09-28 주식회사유한양행 신규의 이미다조[1,2-ａ]피리딘 유도체 및 그의 제조방법
CA2601250C (fr) 2005-03-16 2014-10-28 Nycomed Gmbh Forme posologique a gout masque
TW200700064A (en) * 2005-03-24 2007-01-01 Glaxo Group Ltd Novel compounds
US8884034B2 (en) 2009-07-08 2014-11-11 Dermira (Canada), Inc. TOFA analogs useful in treating dermatological disorders or conditions
EP2452680B1 (fr) 2009-07-09 2019-12-18 RaQualia Pharma Inc. Antagoniste de la pompe à acide destiné au traitement de maladies associées à un transit gastro-intestinal anormal

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA81219B (en) * 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
DE3269604D1 (en) 1981-06-26 1986-04-10 Schering Corp Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
US4725601A (en) 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers

Also Published As

Publication number Publication date
ES2201769T3 (es) 2004-03-16
NO20010861D0 (no) 2001-02-20
PT1105390E (pt) 2003-10-31
WO2000010999A2 (fr) 2000-03-02
CN1161355C (zh) 2004-08-11
WO2000010999A3 (fr) 2000-06-02
CN1323308A (zh) 2001-11-21
MY121387A (en) 2006-01-28
IL141165A0 (en) 2002-11-10
NO20010861L (no) 2001-04-10
AU5767899A (en) 2000-03-14
AU770511B2 (en) 2004-02-26
DK1105390T3 (da) 2003-09-22
BR9913102A (pt) 2001-05-08
NZ509744A (en) 2003-05-30
JP2002523414A (ja) 2002-07-30
CA2339372A1 (fr) 2000-03-02
DE69908608T2 (de) 2004-04-29
HK1036274A1 (en) 2001-12-28
AR020225A1 (es) 2002-05-02
EP1105390B1 (fr) 2003-06-04
DE69908608D1 (de) 2003-07-10
EP1105390A2 (fr) 2001-06-13
ZA200100911B (en) 2002-05-02
KR20010072797A (ko) 2001-07-31
ATE242242T1 (de) 2003-06-15
US6613775B1 (en) 2003-09-02

Similar Documents

Publication Publication Date Title
SE9704404D0 (sv) New compounds
SE9801526D0 (sv) New compounds
SE9802794D0 (sv) New compounds
SE9802793D0 (sv) New compounds
SE9700661D0 (sv) New compounds
SE9602286D0 (sv) New compounds
SE9401197D0 (sv) Active compounds
SE0102808D0 (sv) New compounds
NO984950D0 (no) Forbindelser med veksthormonfrigj°rende egenskaper
FI955896A0 (fi) Uudet aktiiviset yhdisteet
MX9704136A (es) Compuestos para la inhibicion de la secrecion de acido gastrico.
SE0301905D0 (sv) Novel imidazopyridine compound I with therapeutic effect
AR044855A1 (es) Compuesto de imidazopiridina
SE0301903D0 (sv) Novel imidazopyridine compound III with therapeutic effect
AR044854A1 (es) Compuesto de imidazopiridina